世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

処方皮膚科治療薬の世界市場成長(現状と展望)2024-2030年


Global Prescription Dermatology Therapeutics Market Growth (Status and Outlook) 2024-2030

LPI(LPインフォメーション)の最新調査によると、処方皮膚科治療薬の世界市場規模は2023年に2億6280万米ドルと評価されました。下流市場での需要拡大に伴い、処方皮膚科治療薬は2030年までに384億9000万米ドルの... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2024年3月8日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
118 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

LPI(LPインフォメーション)の最新調査によると、処方皮膚科治療薬の世界市場規模は2023年に2億6280万米ドルと評価されました。下流市場での需要拡大に伴い、処方皮膚科治療薬は2030年までに384億9000万米ドルの再調整規模になると予測され、レビュー期間中のCAGRは5.6%です。
この調査レポートは、世界の処方皮膚科治療薬市場の成長可能性を明らかにしています。処方皮膚科治療薬は、今後の市場でも安定した成長が見込まれます。しかし、処方皮膚科治療薬の普及には、製品の差別化、コスト削減、サプライチェーンの最適化が引き続き重要です。市場プレーヤーは、処方皮膚科治療薬市場がもたらす絶大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを築き、進化する消費者の嗜好に合わせた製品を提供する必要があります。
世界の医薬品市場は、2022年には1475億ドルに達し、今後6年間のCAGRは5%で成長する。医薬品市場には、化学医薬品と生物学的医薬品が含まれる。生物製剤は2022年に3810億ドルになると予想されています。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要としている患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の大流行はワクチン開発とサプライチェーン管理の重要性を浮き彫りにし、製薬企業が公衆衛生の新たなニーズに機敏に対応する必要性をさらに強調している。
主な特徴
処方皮膚科治療薬市場に関する本レポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。
市場規模と成長:この調査レポートは、処方皮膚科治療薬市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分(真菌感染症治療薬、皮膚癌治療薬など)、地域別内訳などが含まれます。
市場促進要因と課題:レポートでは、政府規制、環境問題、技術の進歩、消費者の嗜好の変化など、処方皮膚科治療薬市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、高額な初期費用など、業界が直面する課題も浮き彫りにすることができます。
競合情勢:この調査レポートは、処方皮膚科治療薬市場における競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれます。また、新興企業や市場に影響を与える可能性のある企業にもスポットを当てています。
技術開発:調査レポートは、処方皮膚科治療薬業界における最新の技術開発を掘り下げることができます。これには、処方皮膚科治療薬技術の進歩、処方皮膚科治療薬の新規参入、処方皮膚科治療薬の新規投資、処方皮膚科治療薬の将来を形作るその他の技術革新などが含まれます。
川下の事業者の好み:このレポートは、処方皮膚科治療薬市場における顧客の購買行動や採用動向を明らかにします。顧客の購買決定や処方皮膚科治療薬製品の嗜好に影響を与える要因も含まれています。
政府の政策とインセンティブこの調査レポートは、政府の政策やインセンティブが処方皮膚科治療薬市場に与える影響を分析しています。これには、規制枠組み、補助金、税制優遇措置など、処方皮膚科治療薬市場の促進を目的とした施策の評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。
環境への影響と持続可能性この調査レポートは、処方皮膚科治療薬市場の環境への影響と持続可能性の側面を評価します。
市場予測と将来展望:調査レポートでは、実施した分析に基づいて、処方皮膚科治療薬産業の市場予測と展望を提供しています。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、処方皮膚科治療薬市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場の細分化
処方皮膚科治療薬市場はタイプ別と用途別に分類されます。2019-2030年の期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を提供します。
タイプ別セグメント
真菌感染症治療薬
皮膚がん治療薬
にきび・酒さ治療薬
乾癬治療薬
皮膚炎および脂漏症治療薬
用途別セグメント
病院薬局
小売薬局
オンライン薬局
本レポートは地域別にも市場を分割しています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
ファイザー
アッヴィ
ジョンソン・エンド・ジョンソン
ノバルティス
アムジェン
イーライリリー
セルジーン
レオファーマ
ボシュ・ヘルス・カンパニーズ
サン・ファーマシューティカル
アクラリス・セラピューティクス


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prescription Dermatology Therapeutics Market Size 2019-2030
2.1.2 Prescription Dermatology Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Prescription Dermatology Therapeutics Segment by Type
2.2.1 Fungal Infection Drugs
2.2.2 Skin Cancer Drugs
2.2.3 Acne & Rosacea Drugs
2.2.4 Psoriasis Drugs
2.2.5 Dermatitis & Seborrhea Drugs
2.3 Prescription Dermatology Therapeutics Market Size by Type
2.3.1 Prescription Dermatology Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Prescription Dermatology Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Prescription Dermatology Therapeutics Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Prescription Dermatology Therapeutics Market Size by Application
2.5.1 Prescription Dermatology Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Prescription Dermatology Therapeutics Market Size Market Share by Application (2019-2024)
3 Prescription Dermatology Therapeutics Market Size by Player
3.1 Prescription Dermatology Therapeutics Market Size Market Share by Players
3.1.1 Global Prescription Dermatology Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Prescription Dermatology Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Prescription Dermatology Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Prescription Dermatology Therapeutics by Regions
4.1 Prescription Dermatology Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Prescription Dermatology Therapeutics Market Size Growth (2019-2024)
4.3 APAC Prescription Dermatology Therapeutics Market Size Growth (2019-2024)
4.4 Europe Prescription Dermatology Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Prescription Dermatology Therapeutics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Prescription Dermatology Therapeutics Market Size by Country (2019-2024)
5.2 Americas Prescription Dermatology Therapeutics Market Size by Type (2019-2024)
5.3 Americas Prescription Dermatology Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prescription Dermatology Therapeutics Market Size by Region (2019-2024)
6.2 APAC Prescription Dermatology Therapeutics Market Size by Type (2019-2024)
6.3 APAC Prescription Dermatology Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Prescription Dermatology Therapeutics by Country (2019-2024)
7.2 Europe Prescription Dermatology Therapeutics Market Size by Type (2019-2024)
7.3 Europe Prescription Dermatology Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prescription Dermatology Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Prescription Dermatology Therapeutics Market Forecast
10.1 Global Prescription Dermatology Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Prescription Dermatology Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Prescription Dermatology Therapeutics Forecast
10.1.3 APAC Prescription Dermatology Therapeutics Forecast
10.1.4 Europe Prescription Dermatology Therapeutics Forecast
10.1.5 Middle East & Africa Prescription Dermatology Therapeutics Forecast
10.2 Americas Prescription Dermatology Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Prescription Dermatology Therapeutics Market Forecast
10.2.2 Canada Prescription Dermatology Therapeutics Market Forecast
10.2.3 Mexico Prescription Dermatology Therapeutics Market Forecast
10.2.4 Brazil Prescription Dermatology Therapeutics Market Forecast
10.3 APAC Prescription Dermatology Therapeutics Forecast by Region (2025-2030)
10.3.1 China Prescription Dermatology Therapeutics Market Forecast
10.3.2 Japan Prescription Dermatology Therapeutics Market Forecast
10.3.3 Korea Prescription Dermatology Therapeutics Market Forecast
10.3.4 Southeast Asia Prescription Dermatology Therapeutics Market Forecast
10.3.5 India Prescription Dermatology Therapeutics Market Forecast
10.3.6 Australia Prescription Dermatology Therapeutics Market Forecast
10.4 Europe Prescription Dermatology Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Prescription Dermatology Therapeutics Market Forecast
10.4.2 France Prescription Dermatology Therapeutics Market Forecast
10.4.3 UK Prescription Dermatology Therapeutics Market Forecast
10.4.4 Italy Prescription Dermatology Therapeutics Market Forecast
10.4.5 Russia Prescription Dermatology Therapeutics Market Forecast
10.5 Middle East & Africa Prescription Dermatology Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Prescription Dermatology Therapeutics Market Forecast
10.5.2 South Africa Prescription Dermatology Therapeutics Market Forecast
10.5.3 Israel Prescription Dermatology Therapeutics Market Forecast
10.5.4 Turkey Prescription Dermatology Therapeutics Market Forecast
10.5.5 GCC Countries Prescription Dermatology Therapeutics Market Forecast
10.6 Global Prescription Dermatology Therapeutics Forecast by Type (2025-2030)
10.7 Global Prescription Dermatology Therapeutics Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Prescription Dermatology Therapeutics Product Offered
11.1.3 Pfizer Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 AbbVie
11.2.1 AbbVie Company Information
11.2.2 AbbVie Prescription Dermatology Therapeutics Product Offered
11.2.3 AbbVie Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AbbVie Main Business Overview
11.2.5 AbbVie Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Prescription Dermatology Therapeutics Product Offered
11.3.3 Johnson & Johnson Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Prescription Dermatology Therapeutics Product Offered
11.4.3 Novartis Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Amgen
11.5.1 Amgen Company Information
11.5.2 Amgen Prescription Dermatology Therapeutics Product Offered
11.5.3 Amgen Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Amgen Main Business Overview
11.5.5 Amgen Latest Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Information
11.6.2 Eli Lilly Prescription Dermatology Therapeutics Product Offered
11.6.3 Eli Lilly Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Eli Lilly Main Business Overview
11.6.5 Eli Lilly Latest Developments
11.7 Celgene
11.7.1 Celgene Company Information
11.7.2 Celgene Prescription Dermatology Therapeutics Product Offered
11.7.3 Celgene Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Celgene Main Business Overview
11.7.5 Celgene Latest Developments
11.8 LEO Pharma
11.8.1 LEO Pharma Company Information
11.8.2 LEO Pharma Prescription Dermatology Therapeutics Product Offered
11.8.3 LEO Pharma Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 LEO Pharma Main Business Overview
11.8.5 LEO Pharma Latest Developments
11.9 Bausch Health Companies
11.9.1 Bausch Health Companies Company Information
11.9.2 Bausch Health Companies Prescription Dermatology Therapeutics Product Offered
11.9.3 Bausch Health Companies Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Bausch Health Companies Main Business Overview
11.9.5 Bausch Health Companies Latest Developments
11.10 Sun Pharmaceutical
11.10.1 Sun Pharmaceutical Company Information
11.10.2 Sun Pharmaceutical Prescription Dermatology Therapeutics Product Offered
11.10.3 Sun Pharmaceutical Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Sun Pharmaceutical Main Business Overview
11.10.5 Sun Pharmaceutical Latest Developments
11.11 Aclaris Therapeutics
11.11.1 Aclaris Therapeutics Company Information
11.11.2 Aclaris Therapeutics Prescription Dermatology Therapeutics Product Offered
11.11.3 Aclaris Therapeutics Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Aclaris Therapeutics Main Business Overview
11.11.5 Aclaris Therapeutics Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

According to our LPI (LP Information) latest study, the global Prescription Dermatology Therapeutics market size was valued at US$ 26280 million in 2023. With growing demand in downstream market, the Prescription Dermatology Therapeutics is forecast to a readjusted size of US$ 38490 million by 2030 with a CAGR of 5.6% during review period.
The research report highlights the growth potential of the global Prescription Dermatology Therapeutics market. Prescription Dermatology Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Prescription Dermatology Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Prescription Dermatology Therapeutics market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Prescription Dermatology Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Prescription Dermatology Therapeutics market. It may include historical data, market segmentation by Type (e.g., Fungal Infection Drugs, Skin Cancer Drugs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Prescription Dermatology Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Prescription Dermatology Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Prescription Dermatology Therapeutics industry. This include advancements in Prescription Dermatology Therapeutics technology, Prescription Dermatology Therapeutics new entrants, Prescription Dermatology Therapeutics new investment, and other innovations that are shaping the future of Prescription Dermatology Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Prescription Dermatology Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Prescription Dermatology Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Prescription Dermatology Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Prescription Dermatology Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Prescription Dermatology Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Prescription Dermatology Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Prescription Dermatology Therapeutics market.
Market Segmentation:
Prescription Dermatology Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Fungal Infection Drugs
Skin Cancer Drugs
Acne & Rosacea Drugs
Psoriasis Drugs
Dermatitis & Seborrhea Drugs
Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
AbbVie
Johnson & Johnson
Novartis
Amgen
Eli Lilly
Celgene
LEO Pharma
Bausch Health Companies
Sun Pharmaceutical
Aclaris Therapeutics



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prescription Dermatology Therapeutics Market Size 2019-2030
2.1.2 Prescription Dermatology Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Prescription Dermatology Therapeutics Segment by Type
2.2.1 Fungal Infection Drugs
2.2.2 Skin Cancer Drugs
2.2.3 Acne & Rosacea Drugs
2.2.4 Psoriasis Drugs
2.2.5 Dermatitis & Seborrhea Drugs
2.3 Prescription Dermatology Therapeutics Market Size by Type
2.3.1 Prescription Dermatology Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Prescription Dermatology Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Prescription Dermatology Therapeutics Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Prescription Dermatology Therapeutics Market Size by Application
2.5.1 Prescription Dermatology Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Prescription Dermatology Therapeutics Market Size Market Share by Application (2019-2024)
3 Prescription Dermatology Therapeutics Market Size by Player
3.1 Prescription Dermatology Therapeutics Market Size Market Share by Players
3.1.1 Global Prescription Dermatology Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Prescription Dermatology Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Prescription Dermatology Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Prescription Dermatology Therapeutics by Regions
4.1 Prescription Dermatology Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Prescription Dermatology Therapeutics Market Size Growth (2019-2024)
4.3 APAC Prescription Dermatology Therapeutics Market Size Growth (2019-2024)
4.4 Europe Prescription Dermatology Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Prescription Dermatology Therapeutics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Prescription Dermatology Therapeutics Market Size by Country (2019-2024)
5.2 Americas Prescription Dermatology Therapeutics Market Size by Type (2019-2024)
5.3 Americas Prescription Dermatology Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prescription Dermatology Therapeutics Market Size by Region (2019-2024)
6.2 APAC Prescription Dermatology Therapeutics Market Size by Type (2019-2024)
6.3 APAC Prescription Dermatology Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Prescription Dermatology Therapeutics by Country (2019-2024)
7.2 Europe Prescription Dermatology Therapeutics Market Size by Type (2019-2024)
7.3 Europe Prescription Dermatology Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prescription Dermatology Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Prescription Dermatology Therapeutics Market Forecast
10.1 Global Prescription Dermatology Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Prescription Dermatology Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Prescription Dermatology Therapeutics Forecast
10.1.3 APAC Prescription Dermatology Therapeutics Forecast
10.1.4 Europe Prescription Dermatology Therapeutics Forecast
10.1.5 Middle East & Africa Prescription Dermatology Therapeutics Forecast
10.2 Americas Prescription Dermatology Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Prescription Dermatology Therapeutics Market Forecast
10.2.2 Canada Prescription Dermatology Therapeutics Market Forecast
10.2.3 Mexico Prescription Dermatology Therapeutics Market Forecast
10.2.4 Brazil Prescription Dermatology Therapeutics Market Forecast
10.3 APAC Prescription Dermatology Therapeutics Forecast by Region (2025-2030)
10.3.1 China Prescription Dermatology Therapeutics Market Forecast
10.3.2 Japan Prescription Dermatology Therapeutics Market Forecast
10.3.3 Korea Prescription Dermatology Therapeutics Market Forecast
10.3.4 Southeast Asia Prescription Dermatology Therapeutics Market Forecast
10.3.5 India Prescription Dermatology Therapeutics Market Forecast
10.3.6 Australia Prescription Dermatology Therapeutics Market Forecast
10.4 Europe Prescription Dermatology Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Prescription Dermatology Therapeutics Market Forecast
10.4.2 France Prescription Dermatology Therapeutics Market Forecast
10.4.3 UK Prescription Dermatology Therapeutics Market Forecast
10.4.4 Italy Prescription Dermatology Therapeutics Market Forecast
10.4.5 Russia Prescription Dermatology Therapeutics Market Forecast
10.5 Middle East & Africa Prescription Dermatology Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Prescription Dermatology Therapeutics Market Forecast
10.5.2 South Africa Prescription Dermatology Therapeutics Market Forecast
10.5.3 Israel Prescription Dermatology Therapeutics Market Forecast
10.5.4 Turkey Prescription Dermatology Therapeutics Market Forecast
10.5.5 GCC Countries Prescription Dermatology Therapeutics Market Forecast
10.6 Global Prescription Dermatology Therapeutics Forecast by Type (2025-2030)
10.7 Global Prescription Dermatology Therapeutics Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Prescription Dermatology Therapeutics Product Offered
11.1.3 Pfizer Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 AbbVie
11.2.1 AbbVie Company Information
11.2.2 AbbVie Prescription Dermatology Therapeutics Product Offered
11.2.3 AbbVie Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AbbVie Main Business Overview
11.2.5 AbbVie Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Prescription Dermatology Therapeutics Product Offered
11.3.3 Johnson & Johnson Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Prescription Dermatology Therapeutics Product Offered
11.4.3 Novartis Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Amgen
11.5.1 Amgen Company Information
11.5.2 Amgen Prescription Dermatology Therapeutics Product Offered
11.5.3 Amgen Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Amgen Main Business Overview
11.5.5 Amgen Latest Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Information
11.6.2 Eli Lilly Prescription Dermatology Therapeutics Product Offered
11.6.3 Eli Lilly Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Eli Lilly Main Business Overview
11.6.5 Eli Lilly Latest Developments
11.7 Celgene
11.7.1 Celgene Company Information
11.7.2 Celgene Prescription Dermatology Therapeutics Product Offered
11.7.3 Celgene Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Celgene Main Business Overview
11.7.5 Celgene Latest Developments
11.8 LEO Pharma
11.8.1 LEO Pharma Company Information
11.8.2 LEO Pharma Prescription Dermatology Therapeutics Product Offered
11.8.3 LEO Pharma Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 LEO Pharma Main Business Overview
11.8.5 LEO Pharma Latest Developments
11.9 Bausch Health Companies
11.9.1 Bausch Health Companies Company Information
11.9.2 Bausch Health Companies Prescription Dermatology Therapeutics Product Offered
11.9.3 Bausch Health Companies Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Bausch Health Companies Main Business Overview
11.9.5 Bausch Health Companies Latest Developments
11.10 Sun Pharmaceutical
11.10.1 Sun Pharmaceutical Company Information
11.10.2 Sun Pharmaceutical Prescription Dermatology Therapeutics Product Offered
11.10.3 Sun Pharmaceutical Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Sun Pharmaceutical Main Business Overview
11.10.5 Sun Pharmaceutical Latest Developments
11.11 Aclaris Therapeutics
11.11.1 Aclaris Therapeutics Company Information
11.11.2 Aclaris Therapeutics Prescription Dermatology Therapeutics Product Offered
11.11.3 Aclaris Therapeutics Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Aclaris Therapeutics Main Business Overview
11.11.5 Aclaris Therapeutics Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る